280 related articles for article (PubMed ID: 25487422)
21. Structural basis of selective cannabinoid CB
Li X; Chang H; Bouma J; de Paus LV; Mukhopadhyay P; Paloczi J; Mustafa M; van der Horst C; Kumar SS; Wu L; Yu Y; van den Berg RJBHN; Janssen APA; Lichtman A; Liu ZJ; Pacher P; van der Stelt M; Heitman LH; Hua T
Nat Commun; 2023 Mar; 14(1):1447. PubMed ID: 36922494
[TBL] [Abstract][Full Text] [Related]
22. Modern approaches to the development of synthetic cannabinoid receptor probes.
Saldaña-Shumaker SL; Grenning AJ; Cunningham CW
Pharmacol Biochem Behav; 2021 Apr; 203():173119. PubMed ID: 33508249
[TBL] [Abstract][Full Text] [Related]
23. Binding Site Characterization of AM1336, a Novel Covalent Inverse Agonist at Human Cannabinoid 2 Receptor, Using Mass Spectrometric Analysis.
Mallipeddi S; Kreimer S; Zvonok N; Vemuri K; Karger BL; Ivanov AR; Makriyannis A
J Proteome Res; 2017 Jul; 16(7):2419-2428. PubMed ID: 28374590
[TBL] [Abstract][Full Text] [Related]
24. Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells.
Capozzi A; Mattei V; Martellucci S; Manganelli V; Saccomanni G; Garofalo T; Sorice M; Manera C; Misasi R
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29973514
[TBL] [Abstract][Full Text] [Related]
25. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
Pandey P; Roy KK; Doerksen RJ
J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.
Amenta PS; Jallo JI; Tuma RF; Hooper DC; Elliott MB
J Neuroinflammation; 2014 Nov; 11():191. PubMed ID: 25416141
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease.
González-Naranjo P; Pérez-Macias N; Campillo NE; Pérez C; Arán VJ; Girón R; Sánchez-Robles E; Martín MI; Gómez-Cañas M; García-Arencibia M; Fernández-Ruiz J; Páez JA
Eur J Med Chem; 2014 Feb; 73():56-72. PubMed ID: 24378710
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid CB
Soethoudt M; Grether U; Fingerle J; Grim TW; Fezza F; de Petrocellis L; Ullmer C; Rothenhäusler B; Perret C; van Gils N; Finlay D; MacDonald C; Chicca A; Gens MD; Stuart J; de Vries H; Mastrangelo N; Xia L; Alachouzos G; Baggelaar MP; Martella A; Mock ED; Deng H; Heitman LH; Connor M; Di Marzo V; Gertsch J; Lichtman AH; Maccarrone M; Pacher P; Glass M; van der Stelt M
Nat Commun; 2017 Jan; 8():13958. PubMed ID: 28045021
[TBL] [Abstract][Full Text] [Related]
29. Latest progress in the identification of novel synthetic ligands for the cannabinoid CB2 receptor.
Han S; Chen JJ; Chen JZ
Mini Rev Med Chem; 2014 May; 14(5):426-43. PubMed ID: 24766386
[TBL] [Abstract][Full Text] [Related]
30. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
Tai S; Vasiljevik T; Sherwood AM; Eddington S; Wilson CD; Prisinzano TE; Fantegrossi WE
Drug Alcohol Depend; 2018 Nov; 192():285-293. PubMed ID: 30300803
[TBL] [Abstract][Full Text] [Related]
31. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR
Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280
[TBL] [Abstract][Full Text] [Related]
32. Activation of type 2 cannabinoid receptor (CB2R) by selective agonists regulates the deposition and remodelling of the extracellular matrix.
Guan T; Zhao G; Duan H; Liu Y; Zhao F
Biomed Pharmacother; 2017 Nov; 95():1704-1709. PubMed ID: 28958132
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous optimization of potency, selectivity and physicochemical properties for cannabinoid CB(2) ligands.
Worm K; Dolle RE
Curr Pharm Des; 2009; 15(29):3345-66. PubMed ID: 19860684
[TBL] [Abstract][Full Text] [Related]
35. Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases.
Nettekoven M; Adam JM; Bendels S; Bissantz C; Fingerle J; Grether U; Grüner S; Guba W; Kimbara A; Ottaviani G; Püllmann B; Rogers-Evans M; Röver S; Rothenhäusler B; Schmitt S; Schuler F; Schulz-Gasch T; Ullmer C
ChemMedChem; 2016 Jan; 11(2):179-89. PubMed ID: 26228928
[TBL] [Abstract][Full Text] [Related]
36. CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections.
Nagoor Meeran MF; Sharma C; Goyal SN; Kumar S; Ojha S
Drug Dev Res; 2021 Feb; 82(1):7-11. PubMed ID: 33190277
[TBL] [Abstract][Full Text] [Related]
37. Xie2-64, a novel CB
Jordan CJ; Feng ZW; Galaj E; Bi GH; Xue Y; Liang Y; McGuire T; Xie XQ; Xi ZX
Neuropharmacology; 2020 Oct; 176():108241. PubMed ID: 32712273
[TBL] [Abstract][Full Text] [Related]
38. (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB
González-Mariscal I; Carmona-Hidalgo B; Winkler M; Unciti-Broceta JD; Escamilla A; Gómez-Cañas M; Fernández-Ruiz J; Fiebich BL; Romero-Zerbo SY; Bermúdez-Silva FJ; Collado JA; Muñoz E
Pharmacol Res; 2021 Jul; 169():105492. PubMed ID: 34019978
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
40. A pharmacoinformatic approach on Cannabinoid receptor 2 (CB2) and different small molecules: Homology modelling, molecular docking, MD simulations, drug designing and ADME analysis.
Vijayakumar S; Manogar P; Prabhu S; Pugazhenthi M; Praseetha PK
Comput Biol Chem; 2019 Feb; 78():95-107. PubMed ID: 30500557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
